Phio Pharmaceuticals Corp.
PHIOW
Price:
$0.0232
Market Cap:
$11.63M
Phio Pharmaceuticals Corp., a biotechnology company, develops immuno-oncology therapeutics in the United States. It offers INTASYL therapeutic platform focuses on silencing tumor-induced suppression of the immune system. The company develops PH-762 which targets the checkpoint protein PD-1 on immune cells for used in adoptive cell transfer (ACT); PH-804 that targets the suppressive immune receptor TIGIT, which is a checkpoint protein present on T cells and natural killer cells for used in ACT; and PH-790 which targets PD-L1 protein that keeps immune cells from attacking nonharmful cells in the body. It has collaborations with the Gustave Roussy and Medigene AG, as well as with Helmholtz Zent...[Read more]
Industry
Biotechnology
IPO Date
2022-01-31
Stock Exchange
NASDAQ
Ticker
PHIOW
PE Ratio
[-0.02]
ROE
[-86.38%]
Current Ratio
[22.27]
Dividend Yield
[0%]
Enterprise Value
[920.58K]
Dividend History
The ROE as of December 2025 (TTM) for Phio Pharmaceuticals Corp. (PHIOW) is -86.38%
According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current ROE is -86.38%. This represents a change of 264.75% compared to the average of -23.68% of the last 4 quarters.
Phio Pharmaceuticals Corp. (PHIOW) Historical ROE (quarterly & annually)
How has PHIOW ROE performed in the past?
The mean historical ROE of Phio Pharmaceuticals Corp. over the last ten years is -161.07%. The current -86.38% ROE has changed -46.37% with respect to the historical average. Over the past ten years (40 quarters), PHIOW's ROE was at its highest in in the June 2021 quarter at -9.32%. The ROE was at its lowest in in the March 2018 quarter at -394.89%.
Average
-161.07%
Median
-110.45%
Minimum
-679.32%
Maximum
-54.21%
Phio Pharmaceuticals Corp. (PHIOW) ROE by Quarter and Year
Discovering the peaks and valleys of Phio Pharmaceuticals Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 719.89%
Maximum Annual ROE = -54.21%
Minimum Annual Increase = -92.02%
Minimum Annual ROE = -679.32%
| Year | ROE | Change |
|---|---|---|
| 2024 | -151.39% | 8.09% |
| 2023 | -140.05% | 32.24% |
| 2022 | -105.90% | 74.81% |
| 2021 | -60.58% | -10.32% |
| 2020 | -67.56% | -56.08% |
| 2019 | -153.81% | 183.75% |
| 2018 | -54.21% | -92.02% |
| 2017 | -679.32% | 719.89% |
| 2016 | -82.86% | -27.95% |
| 2015 | -114.99% | -64.13% |
Phio Pharmaceuticals Corp. (PHIOW) Average ROE
How has PHIOW ROE performed in the past?
The current ROE of Phio Pharmaceuticals Corp. (PHIOW) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-132.45%
5-year avg
-105.10%
10-year avg
-161.07%
Phio Pharmaceuticals Corp. (PHIOW) ROE vs. Peers
How is PHIOW’s ROE compared to its peers?
Phio Pharmaceuticals Corp.’s ROE is greater than Ontrak, Inc. (-269.88%), greater than BiomX Inc. (-190.95%), greater than TFF Pharmaceuticals, Inc. (-178.03%), greater than Biocept, Inc. (-138.49%), less than Peak Bio, Inc. (1.68%), greater than TC Biopharm (Holdings) Plc (-391.64%), greater than GBS Inc. (-227.53%), greater than Virios Therapeutics, Inc. (-826.09%), greater than LakeShore Biopharma Co., Ltd (-18.43%), less than Seelos Therapeutics, Inc. (171.72%),
| Company | ROE | Market cap |
|---|---|---|
| -269.88% | $2.34M | |
| -190.95% | $2.37M | |
| -178.03% | $288.80K | |
| -138.49% | $450.79K | |
| 1.68% | $520.31K | |
| -391.64% | $256.50K | |
| -227.53% | $433.58K | |
| -826.09% | $206.50K | |
| -18.43% | $25.84M | |
| 171.72% | $214.97K |
Build a custom stock screener for Phio Pharmaceuticals Corp. (PHIOW) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Phio Pharmaceuticals Corp. (PHIOW) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Phio Pharmaceuticals Corp.'s ROE?
How is the ROE calculated for Phio Pharmaceuticals Corp. (PHIOW)?
What is the highest ROE for Phio Pharmaceuticals Corp. (PHIOW)?
What is the 3-year average ROE for Phio Pharmaceuticals Corp. (PHIOW)?
What is the 5-year average ROE for Phio Pharmaceuticals Corp. (PHIOW)?
How does the current ROE for Phio Pharmaceuticals Corp. (PHIOW) compare to its historical average?